References
- Hutchinson KA. Androgens and sexuality. Am J Med 1995;98: 111–58
- Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456–60
- Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990;75:26–30S
- Nathorst-Boos J, Wiklund I, Mattsson LA, . Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656–60
- Myers LS, Dixen J, Morisette D, . Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 1990;70:1124–31
- Serin IS, Ozcelik B, Basbug M, . Long term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels. Eur J Obstet Gynecol Reprod Biol 2001;99:222–5
- Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–53
- Santoro N, Torrens J, Crawfors S, . Correlates of circulating androgens in mid-life women: the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2005;90: 4836–45
- Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–9
- Genazzani AD, Lanzoni C, Genazzani AR. Might DHEA be a beneficial replacement therapy in the elderly? Drugs Aging 2007;24:173–85
- Mortola JF, Yen SCC. The effects of oral dehydroepiandrosterone on endocrine-metabolic in postmenopausal women. J Clin Endocrinol Metab 1990;71:696–704
- Simoncini T, Genazzani AR. Dehydroepiandrosterone, the endothelium and cardiovascular protection. Endocrinology 2007;148:3065–7
- Buvat J. Androgen therapy with dehydroepiandrosterone. World J Urol 2003;21:346–55
- Labrie F, Archer D, Bouchard C, . Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897–906.
- Davis SR, Shah SM, McKenzie DP, . Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women. J Clin Endocrinol Metab 2008;93:801–8
- Genazzani AR, Pluchino N. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence. Climacteric 2010;13:314–16.
- Pluchino N, Ninni F, Stomati M, . One year therapy with 10 mg/die DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas 2008;59:296–303
- Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update 2007;13: 239–48
- Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847–56
- Von Mühlen D, Laughlin GA, Kritz-Silverstein D, . The dehydroepiandrosterone and wellness (DAWN) study: research design and methods. Contemp Clin Trials 2007;28: 153–68
- Nappi RE. Sexuality and menopause. In Erkkola R, ed. The Menopause. Philadelphia: Elsevier, 2006:143–54
- McCoy NL. McCoy Female Sexuality Questionnaire. Qual Life Res 2000;9:739–45
- Rellini AH, Nappi RE, Vaccaro P, . Validation of the McCoy female Sexuality Questionnaire in an Italian sample. Arch Sex Behav 2005;34:641–7.
- Genazzani AR, Petraglia F, Bernardi F, . Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J Clin Endocrinol Metab 1998;83:2099–103
- Stomati M, Bersi C, Rubino S, . Neuroendocrine effects of different oestradiol-progestin regimens in postmenopausal women. Maturitas 1997;28:127–35
- Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25–31.
- Panjari M, Davis SR. DHEA for postmenopausal women: a review of the evidence. Maturitas 2010;66:172–9
- Nair KS, Rizza RA, O'Brein P, . DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;335:1647–59
- Labrie F, Luu-The V, Bélanger A, . Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169–96
- Davis SR. The effects of tibolone on mood and libido. Menopause 2002;9:162–70
- Pluchino N, Genazzani AD, Bernardi F, . Tibolone, transdermal estradiol or oral estrogen-progestin therapy: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol Endocrinol 2005;20:144–9
- Biglia N, Maffei S, Lello S, Nappi RE. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecol Endocrinol 2010;26:804–14
- Labrie F, Archer D, Bouchard C, . Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009;16:923–31